B. Riley Securities is pleased to announce the Neuro & Ophthalmology Investor Conference on April 27-28, 2022. Please contact [email protected] for more information or visit our website: https://t.co/rWKMDZiTNZ
Congratulations to BRVC portfolio company @uniphore on its largest round of funding to date, and $2.5 Billion valuation. Click here for details.
https://t.co/Ry4JdSKhvL
We are honored to be ranked #2 in @FortuneMagazine's 100 Fastest-Growing Companies in 2021 - credited to the caliber of our people and unified approach in building a one-of-a-kind, diverse financial services platform.
https://t.co/M9oUlb83m0
https://t.co/KFpVNNmDec
B. Riley Securities’ Biotech Research Team is thrilled to announce the next management and KOL discussion of the Fall 2021 “Best Ideas” in Oncology Virtual Panel Series: Overcoming Checkpoint Resistance in Solid Tumors. For more information, please contact [email protected].